ArticleFrontiers in pharmacology2026

Melatonin: a promising therapy to combat type 2 airway inflammation via MT1-Sirt1 pathway.

Zhe Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.